AtriCure
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, AtriCure sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).
AtriCure: 23 sponsored US clinical trials, 5 recruiting.
AtriCure sponsors 23 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 14 completed. 3 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atrial Fibrillation, with 3 trials.
Top-decile sponsor footprint
AtriCure ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
23 total, page 1 of 1
BoxX-NoAF Clinical Trial
NCT06989775
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
NCT06908538
Inappropriate Sinus Tachycardia Registry
NCT05107635
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
NCT05110989
Tracking Results of Ablations to Combat AF Registry Generation 2
NCT05111015
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304
HEAL-IST IDE Trial
NCT05280093
CONVERGE Post-Approval Study (PAS)
NCT05393180
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
NCT03732794
FREEZE-AFIB Post-Market Study
NCT05089877
VCLIP Post-Market Study, Long-term Follow-up on LAA Exclusion Using AtriClip
NCT05101993
aMAZE Trial Continued Access Protocol
NCT04468334
The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)
NCT02922153
AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)
NCT02701062
Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
NCT02393885
Stroke Feasibility Study
NCT01997905
CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)
NCT01984346
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation
NCT01694563
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
NCT01661205
Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study
NCT01246466
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
NCT00779857
AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation
NCT00560885
Concomitant Treatment of Permanent Atrial Fibrillation
NCT00566787
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the AtriCure pipeline
5 recruiting of 23 indexed (22% open); 14 completed (61%).
Phase mix: 3 late (III/IV) vs 2 early (I/II) (balanced across stages).
Top condition: Atrial Fibrillation (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
AtriCure: open-pipeline peers nationwide
Peers matched on 23 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
AtriCure sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 23 trials (± recruiting share)
- AMAG Pharmaceuticals · 23 trials · 9% recruiting
- Cara Therapeutics · 23 trials · 0% recruiting
- Craig L Slingluff, Jr · 23 trials · 4% recruiting
- Duramed Research · 23 trials · 0% recruiting
Sponsors near 22% open enrollment (± trial volume)
- University of Colorado, Boulder · 22% recruiting · 69 trials
- University of Maryland, College Park · 22% recruiting · 46 trials
- Regeneron Pharmaceuticals · 22% recruiting · 280 trials
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 22% recruiting · 60 trials
Related
What to do with this AtriCure page
23 registered trials is a research-attention snapshot, not an endorsement of AtriCure or any single study.
- 5 of AtriCure's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Atrial Fibrillation is the condition AtriCure studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atrial Fibrillation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AtriCure pipeline card: 23 registered trials from official public datasets.Report a data error.